Impact of Preoperative Osteosarcopenia and Postoperative Administration of Pancrelipase on the Prognosis of Borderline Resectable and Unresectable Locally Advanced Pancreatic Cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Osteosarcopenia is a key predictor of recurrence and poor prognosis in advanced pancreatic cancer patients. Pancreatic enzyme replacement therapy may improve outcomes by enhancing muscle health and chemotherapy completion.
Area Of Science
- Oncology
- Gastroenterology
- Geriatrics
Background
- Investigating prognostic factors for borderline resectable (BR) and unresectable locally advanced (UR-LA) pancreatic cancer.
- Focusing on osteosarcopenia as a potential predictor of recurrence and survival.
- Examining the role of postoperative pancreatic enzyme replacement therapy (PERT).
Purpose Of The Study
- Identify independent predictors of postoperative recurrence and prognosis in BR and UR-LA pancreatic cancer.
- Assess the impact of osteosarcopenia on outcomes.
- Evaluate the effect of PERT on sarcopenia, osteopenia, osteosarcopenia, and chemotherapy completion.
Main Methods
- Retrospective analysis of 32 resected BR and UR-LA pancreatic cancer patients.
- Investigated factors influencing disease-free and overall survival.
- Assessed the relationship between osteosarcopenia and clinicopathological factors.
- Analyzed the impact of PERT (pancrelipase ≥6 months) on sarcopenia, osteopenia, osteosarcopenia, and adjuvant chemotherapy completion.
Main Results
- Osteosarcopenia and lymph node metastasis were independent recurrence predictors (P=0.049, P=0.01).
- Osteosarcopenia, tumor diameter ≥40 mm, and lack of adjuvant therapy predicted prognosis (P=0.002, P=0.006, P=0.01).
- PERT improved sarcopenia (P=0.004) and increased adjuvant chemotherapy completion (86% vs 25%, P=0.007).
Conclusions
- Osteosarcopenia is an independent predictor of recurrence and prognosis in locally advanced pancreatic cancer post-pancreatectomy.
- Postoperative PERT may improve prognosis by mitigating sarcopenia and enhancing chemotherapy completion.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Detailed History: Understanding the patient's symptoms is critical. It includes inquiring about abdominal pain, weight loss, and digestive issues, which are common in chronic pancreatitis.
Physical Examination: This might reveal abdominal tenderness, jaundice, and signs of malnutrition,...
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...